Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nucleoside analogues for chronic hepatitis B.

L M Wolters1, H G Niesters, R A de Man

  • 1Department of Gastroenterology & Hepatology, University Hospital Rotterdam, The Netherlands.

European Journal of Gastroenterology & Hepatology
|December 14, 2001
PubMed
Summary

Five nucleoside analogues inhibit hepatitis B virus replication by interfering with reverse transcription. However, potential cytotoxicity and viral resistance necessitate combination therapy for effective future treatment of this viral infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular risk profiles in patients with primary sclerosing cholangitis.

European journal of gastroenterology & hepatology·2026
Same author

Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980-2020.

European journal of internal medicine·2022
Same author

Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report.

Clinics and research in hepatology and gastroenterology·2022
Same author

Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination schedule.

The Netherlands journal of medicine·2020
Same author

Conservative treatment versus elective repair of umbilical hernia in patients with liver cirrhosis and ascites: results of a randomized controlled trial (CRUCIAL trial).

Langenbeck's archives of surgery·2020
Same author

Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab.

ACG case reports journal·2020

Area of Science:

  • Virology
  • Hepatology
  • Pharmacology

Background:

  • Hepatitis B virus (HBV) replication involves reverse transcription by viral polymerase within hepatocytes.
  • Nucleoside/nucleotide analogues are a class of antiviral drugs targeting viral replication.

Purpose of the Study:

  • To describe five nucleoside/nucleotide analogues that inhibit HBV replication.
  • To discuss the implications of cytotoxicity and viral resistance to nucleoside analogue therapy.

Main Methods:

  • Description of five nucleoside/nucleotide analogues.
  • Analysis of antiviral activity in the context of cellular toxicity.
  • Evaluation of potential for viral polymerase mutations leading to drug resistance.

Main Results:

Related Experiment Videos

  • The described analogues interfere with HBV replication mechanisms.
  • Cytotoxicity is a critical consideration when assessing antiviral efficacy.
  • Prolonged therapy can lead to viral polymerase mutations, resulting in resistance and renewed replication.

Conclusions:

  • Nucleoside analogues offer a strategy to inhibit HBV replication.
  • Interpreting antiviral activity requires careful consideration of cellular toxicity.
  • Combination therapy, potentially involving multiple nucleoside analogues or interferon, represents a promising future strategy against HBV.